HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adam B Polis Selected Research

rofecoxib (Vioxx)

7/2006Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies.
2/2006Treatment of patients with osteoarthritis with rofecoxib compared with nabumetone.
6/2005Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
5/2005The time to onset and overall analgesic efficacy of rofecoxib 50 mg: a meta-analysis of 13 randomized clinical trials.
11/2004Pain management in osteoarthritis: a focus on onset of efficacy--a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials.
5/2004Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.
10/2003Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.
4/2002Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial.
1/2002Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Adam B Polis Research Topics

Disease

8Osteoarthritis
07/2006 - 01/2002
6Pain (Aches)
07/2006 - 01/2002
4Hypercholesterolemia
12/2016 - 06/2009
4Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2016 - 06/2009
3Knee Osteoarthritis
06/2005 - 01/2002
2Cardiovascular Diseases (Cardiovascular Disease)
11/2019 - 06/2009
2Flushing
08/2012 - 02/2010
2Infections
09/2009 - 12/2006
2Wounds and Injuries (Trauma)
03/2007 - 12/2006
2Acute Pain
05/2005 - 04/2002
1Postmenopausal Osteoporosis
12/2019
1Hip Fractures (Intertrochanteric Fractures)
12/2019
1Bone Resorption
12/2019
1Atrial Fibrillation
12/2019
1Myocardial Infarction
12/2019
1Stroke (Strokes)
12/2019
1Osteoporosis
12/2019
1Diabetes Mellitus
12/2016
1Prediabetic State (Prediabetes)
12/2016
1Insulin Resistance
12/2016
1Coronary Disease (Coronary Heart Disease)
03/2016
1Obesity
05/2010
1Type 2 Diabetes Mellitus (MODY)
05/2010
1Hyperlipidemias (Hyperlipidemia)
02/2010
1Vascular Diseases (Vascular Disease)
12/2009
1Wound Infection (Wound Infections)
09/2009
1Diabetic Foot
09/2009
1Hypersensitivity (Allergy)
06/2009
1Hepatitis
06/2009
1Exanthema (Rash)
06/2009
1Inflammation (Inflammations)
12/2006
1Edema (Dropsy)
06/2005
1Hypertension (High Blood Pressure)
06/2005
1Arthritis (Polyarthritis)
10/2003
1Rheumatoid Arthritis
04/2002

Drug/Important Bio-Agent (IBA)

9rofecoxib (Vioxx)FDA Link
07/2006 - 01/2002
5Ezetimibe (Zetia)FDA Link
12/2016 - 06/2009
4Simvastatin (Zocor)FDA LinkGeneric
08/2013 - 06/2009
4Celecoxib (Celebrex)FDA Link
07/2006 - 01/2002
3HDL CholesterolIBA
12/2016 - 05/2010
3Atorvastatin (Lipitor)FDA Link
05/2010 - 06/2009
3C-Reactive ProteinIBA
05/2010 - 12/2006
3NabumetoneFDA LinkGeneric
02/2006 - 05/2004
3Acetaminophen (Paracetamol)FDA LinkGeneric
06/2005 - 01/2002
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
06/2005 - 04/2002
2Glucose (Dextrose)FDA LinkGeneric
12/2016 - 02/2010
2oxidized low density lipoproteinIBA
03/2016 - 12/2009
2ApolipoproteinsIBA
08/2013 - 05/2010
2LDL CholesterolIBA
08/2013 - 12/2009
2Niacin (Nicotinic Acid)FDA LinkGeneric
08/2012 - 02/2010
2Anti-Bacterial Agents (Antibiotics)IBA
09/2009 - 03/2007
2Naproxen (Naprosyn)FDA LinkGeneric
10/2003 - 04/2002
1Cathepsin KIBA
12/2019
1odanacatibIBA
12/2019
1lipoprotein cholesterolIBA
11/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2016
1Triglycerides (Triacylglycerol)IBA
12/2016
1ProstaglandinsIBA
08/2012
1Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link
02/2010
1Lipoproteins (Lipoprotein)IBA
02/2010
1CholesterolIBA
12/2009
1Rosuvastatin Calcium (Crestor)FDA Link
12/2009
1S 10 (S-10)IBA
12/2009
1Adenosine Triphosphate (ATP)IBA
12/2009
1LipidsIBA
06/2009
1Serum AlbuminIBA
03/2007
1Biomarkers (Surrogate Marker)IBA
12/2006
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2003
1Pharmaceutical PreparationsIBA
04/2002
1Ibuprofen (Motrin)FDA LinkGeneric
04/2002
1Diclofenac (SR 38)FDA LinkGeneric
04/2002
1Analgesics (Analgesic Drugs)IBA
04/2002
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2002
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2002

Therapy/Procedure

10Therapeutics
12/2016 - 01/2002
2Analgesia
05/2005 - 04/2002
2Oral Surgery (Maxillofacial Surgery)
05/2005 - 04/2002
1Cholecystectomy
02/2010
1Pain Management
11/2004